| 生物活性 | |||
|---|---|---|---|
| 描述 | PCSK9-IN-10 is a potent and orally active PCSK9 inhibitor with an IC50 value of 6.4 µM. PCSK9-IN-10 enhances the expression of LDLR protein while reducing PCSK9 expression. PCSK9-IN-10 demonstrates efficacy in reducing the progression of atherosclerosis and holds promise for research on hyperlipidemia [1]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
| 1 mM 5 mM 10 mM | 2.68mL 0.54mL 0.27mL | 13.39mL 2.68mL 1.34mL | 26.78mL 5.36mL 2.68mL | 
| 参考文献 | 
|---|